Test Can Reduce Colon Cancer Deaths

Colorectal cancer, commonly referred to as colon cancer, is the second leading cause of cancer death in the United States, according to the American Cancer Society (ACS). But a simple screening test can significantly reduce colon cancer mortality, according to a report in the medical journal Gastroenterology.

In the study, French researchers examined the effectiveness of a biennial (every two years) colorectal screening test. They invited 92,000 Burgundy residents to complete a "fecal occult blood test," or FOBT, which examines stool for tiny amounts of blood. About 69 percent completed at least one screening test while about 38 percent completed five or six screenings. The scientists found that having a FOBT screening at least once reduced the risk of colorectal cancer death by one third. In addition, the 11-year survival rates of patients with cancers identified with a FOBT were significantly higher in the screened group compared with individuals who were not screened (50.5 percent versus 40.4 percent, respectively).

Unfortunately, not enough of the general population adheres to early screening tests - in France and in the United States. According to the ACS, when colon cancers are detected at an early stage (when the cancer is localized), the five-year survival rate is 90 percent. However, because screening rates are so low, only 38 percent of colon cancers are detected at this stage.

In 2004, an estimated 146,940 new cases of colon cancer will be diagnosed in the United States and an estimated 56,730 deaths are expected to occur. You can reduce your risk of colon cancer by adopting a healthy lifestyle, which includes adequate exercise, stress reduction and proper nutrition (including a program of natural supplements specifically designed to help keep your digestive system on track). In addition, the ACS recommends that both men and women over the age of 50 have a yearly FOBT. There are other early detection tests that are available, which include a flexible sigmoidoscopy, a double-contrast barium enema and a colonoscopy. These options should be discussed with your physician to select the test and screening schedule appropriate for you.